Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Helse Nord-Trøndelag HF | OTHER |
| SINTEF Health Research | OTHER |
Not provided
Not provided
Not provided
Not provided
To evaluate the usefulness of Deep neural network (DNN) in the evaluation of mediastinal and hilar lymph nodes with Endobronchial ultrasound (EBUS). The study will explore the feasibility of DNN to identify lymph nodes and blood vessel examined with EBUS.
Multi-center prospective feasibility study. The DNN model will be trained on ultrasound images with annotation to identifies lymph nodes and blood vessels examined with EBUS. The ability of the DNN to segment lymph nodes and vessels based on postoperative processing and static EBUS images will be evaluated in the first part of the study. In the second part of the study Real-time use of DNN in EBUS procedure will be evaluated.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| machine learning algorithm | Device | Machine learning algorithm run on EBUS images for real-time labelling of mediastinal lymph nodes and lymph node level |
| Measure | Description | Time Frame |
|---|---|---|
| Capability | To explore if Deep neural network (DNN) has capability to segment lymph nodes and blood vessels from EBUS images | 8 months |
| Measure | Description | Time Frame |
|---|---|---|
| Precision | The precision the DNN has for detecting lymph nodes and blood vessels. Measured both per voxel in the EBUS images and per annotated structure (a structure is counted as detected if at least 50% of its annotated pixels are identified by the DNN). | 2 months |
| Sensitivity |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patents with undiagnosed enlarged mediastinal and hilar lymph nodes who have been recommended for Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA).
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Øyvind Ervik, MD | Contact | +4791634595 | oyvind.ervik@ntnu.no | |
| Hanne Sorger, MD,PhD | Contact | +4791816787 | hanne.sorger@ntnu.no |
| Name | Affiliation | Role |
|---|---|---|
| Øivind Rognmo, Dr.philos | Norwegian University of Science and Technology | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Pulmonology, Levanger Hospital, North Trøndelag Hospital Trust | Recruiting | Levanger | 7600 | Norway |
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
True positive rate. Correctly detected lymph nodes/blood vessel over total lymph nodes/blood vessel. Measured per pixel in the EBUS images |
| 2 months |
| Specificity | Specificity = (True Negative)/(True Negative + False Positive). Measured per pixel in the EBUS images. | 2 months |
| Dice similarity coefficient | Measures the similarity between two sets of data: Annotated by pulmonologist vs DNN. | 2 months |
| Run-time | Is the run-time sufficiently low for real-time analysis during EBUS? | 2 months |
| Adverse events | Procedure related adverse events or unexpected incidents registered | 48 hours |
| Department of Thoracic Medicine, St Olavs Hospital | Recruiting | Trondheim | 7030 | Norway |
|
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |